Fundraising Fox
Topera
151,940 employees on LinkedIn · 2 known investors
Find your way into Topera
Sign up to see every warm intro you have to Topera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Topera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Abbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
Investors · 2
Acquisitions · 1
Early investors' stakes continue via these dealsOptiMedica
OptiMedica develops ophthalmology equipment for cataract surgery, including phacoemulsification and laser-assisted cataract surgery systems along with intraocular lenses and implants. Its products serve eye surgeons performing cataract procedures.
Frequently asked questions
- What does Topera do?
- Abbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
- Who are Topera's investors?
- Topera's investors include New Enterprise Associates (NEA), OTV.